247 related articles for article (PubMed ID: 10780879)
61. [Detection of chromosomal abnormalities in soft tissue sarcomas: which sarcomas? Which abnormalities? How? Why?].
Genevay M; Gengler C; Guillou L
Bull Cancer; 2007 Sep; 94(9):781-92. PubMed ID: 17878098
[TBL] [Abstract][Full Text] [Related]
62. [Late results of the combined treatment of locally disseminated soft tissue sarcomas].
Trapeznikov NN; Aliev BM; Iur'eva TV
Vopr Onkol; 1982; 28(11):20-4. PubMed ID: 7147827
[TBL] [Abstract][Full Text] [Related]
63. Local recurrence and survival in soft tissue sarcomas: the relation of biopsy.
Thompson RC; Hartman R; Swanson P; Dusenbury K
Chir Organi Mov; 1990; 75(1 Suppl):131-3. PubMed ID: 2249508
[No Abstract] [Full Text] [Related]
64. Chemosensitivity profiles identify polymorphisms in the p53 network genes 14-3-3tau and CD44 that affect sarcoma incidence and survival.
Vazquez A; Grochola LF; Bond EE; Levine AJ; Taubert H; Müller TH; Würl P; Bond GL
Cancer Res; 2010 Jan; 70(1):172-80. PubMed ID: 19996285
[TBL] [Abstract][Full Text] [Related]
65. [Molecular pathology of soft tissue tumors: Contribution to diagnosis and therapy prediction].
Schmitz K; Schildhaus HU
Pathologe; 2015 Mar; 36(2):126-36. PubMed ID: 25822596
[TBL] [Abstract][Full Text] [Related]
66. Forearm soft tissue sarcoma: tumors characteristics and oncologic outcomes following limb salvage surgery.
Baroudi MR; Ferguson PC; Wunder JS; Isler MH; Mottard S; Werier JA; Turcotte RE
J Surg Oncol; 2014 Nov; 110(6):676-81. PubMed ID: 24910319
[TBL] [Abstract][Full Text] [Related]
67. Clinicopathological and prognostic significance of chemokine receptor CXCR4 in patients with bone and soft tissue sarcoma: a meta-analysis.
Li YJ; Dai YL; Zhang WB; Li SJ; Tu CQ
Clin Exp Med; 2017 Feb; 17(1):59-69. PubMed ID: 26678086
[TBL] [Abstract][Full Text] [Related]
68. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: a retrospective immunohistological study including 216 soft tissue sarcomas.
Jensen V; Sørensen FB; Bentzen SM; Ladekarl M; Nielsen OS; Keller J; Jensen OM
Histopathology; 1998 Jun; 32(6):536-46. PubMed ID: 9675593
[TBL] [Abstract][Full Text] [Related]
69. Prognosticators in thigh soft tissue sarcomas.
Newcomer AE; Dylinski D; Rubin BP; Joyce MJ; Hoeltge G; Bershadsky B; Lietman SA
J Surg Oncol; 2011 Jan; 103(1):85-91. PubMed ID: 21165983
[TBL] [Abstract][Full Text] [Related]
70. [Prediction of the metastatic potential of sarcomas on the basis of a gene expression signature related to genome complexity].
Chibon F
Med Sci (Paris); 2011 Jan; 27(1):22-4. PubMed ID: 21299955
[No Abstract] [Full Text] [Related]
71. Evaluation of adjuvant therapy in soft tissue sarcoma. A collaborative multidisciplinary approach. E.O.R.T.C. protocol 62771.
Pinedo HM; Vendrik CP; Bramwell VH; van Slooten EA; Deakin DP; van Unnik JA; Staquet M; Sylvester R; Bonadonna G
Eur J Cancer (1965); 1979 May; 15(5):811-20. PubMed ID: 389637
[No Abstract] [Full Text] [Related]
72. A preclinical model for predicting drug response in soft-tissue sarcoma with targeted AAVP molecular imaging.
Hajitou A; Lev DC; Hannay JA; Korchin B; Staquicini FI; Soghomonyan S; Alauddin MM; Benjamin RS; Pollock RE; Gelovani JG; Pasqualini R; Arap W
Proc Natl Acad Sci U S A; 2008 Mar; 105(11):4471-6. PubMed ID: 18337507
[TBL] [Abstract][Full Text] [Related]
73. The molecular biology of soft tissue sarcomas.
Shipley J; Crew J; Gusterson B
Eur J Cancer; 1993; 29A(14):2054-8. PubMed ID: 8280501
[No Abstract] [Full Text] [Related]
74. [Research progress on long non-coding RNA in bone and soft tissue sarcomas].
Meng L; Liu CX; Li F
Zhonghua Bing Li Xue Za Zhi; 2017 Apr; 46(4):277-279. PubMed ID: 28376603
[No Abstract] [Full Text] [Related]
75. Radiation-induced bone and soft tissue sarcomas: clinical aspects and molecular biology.
Spiro IJ; Suit HD
Cancer Treat Res; 1997; 91():143-55. PubMed ID: 9286494
[No Abstract] [Full Text] [Related]
76. Letter: Familial breast cancer, soft-tissue sarcomas, and other neoplasms.
Li FP; Fraumen JF
Ann Intern Med; 1975 Dec; 83(6):833-4. PubMed ID: 1200533
[No Abstract] [Full Text] [Related]
77. Advances in the understanding of human soft tissue sarcomas: molecular biology and therapeutic strategies (Review).
Milas M; Yu D; Pollock RE
Oncol Rep; 1998; 5(5):1275-9. PubMed ID: 9683850
[TBL] [Abstract][Full Text] [Related]
78. Could spindle cell lung carcinoma be considered and treated as sarcoma, according to its clinical course, morphology, immunophenotype and genetic finding?
Kontic M; Stojsic J; Stevic R; Bunjevacki V; Jekić B; Dobricic V
Pathol Oncol Res; 2013 Jan; 19(1):129-33. PubMed ID: 22923000
[TBL] [Abstract][Full Text] [Related]
79. Editorial: precision medicine of sarcomas and aggressive connective tissue tumours: from one-size-fits-all to haute couture.
Blay JY
Curr Opin Oncol; 2022 Jul; 34(4):320-321. PubMed ID: 35837702
[No Abstract] [Full Text] [Related]
80. CORR Insights®: Detection of Novel Tyrosine Kinase Fusion Genes as Potential Therapeutic Targets in Bone and Soft Tissue Sarcomas Using DNA/RNA-based Clinical Sequencing.
Iwata S
Clin Orthop Relat Res; 2024 Mar; 482(3):564-565. PubMed ID: 38289700
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
